NCT02273895View on ClinicalTrials.gov

The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

January 31, 2010

Conditions
AD
Interventions
DRUG

Scopolamine

0.3 mg/mL, intravenously, once

Sponsors

Lead Sponsor

Mentis Cura
All Listed Sponsors
collaborator

Landspitali University Hospital

OTHER

lead

Mentis Cura

INDUSTRY

NCT02273895 - The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study | Biotech Hunter | Biotech Hunter